CAR T Cells More Powerful When Built With CRISPR, MSK Researchers FindMemorial Sloan Kettering Cancer CenterResearchers from Memorial Sloan Kettering Cancer Center (MSK) have harnessed the power of CRISPR/Cas9 to create more-potent chimeric antigen rec… Continue reading
CAR T cells more powerful when built with CRISPR, MSK researchers findEurekAlert (press release)Researchers from Memorial Sloan Kettering Cancer Center (MSK) have harnessed the power of CRISPR/Cas9 to create more-potent chimeric antigen receptor (CAR) … Continue reading
Philadelphia Business Journal |
Why Spark’s CEO says 2017 may be a ‘historic year’ for his gene therapy company
Philadelphia Business Journal Philadelphia gene therapy company Spark Therapeutics said it is in the final stages of completing its rolling biologics license application for its lead product: a one-time treatment for an inherited retinal disease that causes blindness in children … Spark Therapeutics Reports 2016 Financial Results and Business HighlightsGlobeNewswire (press release) |
MIT News |
3Q: US patent office’s ruling on CRISPR
MIT News Q: What is CRISPR, and what research is being done at MIT and the Broad Institute? A: CRISPR is a naturally occurring system by which bacteria and other microorganisms fight viral infections. CRISPR systems, such as CRISPR-Cas9 and CRISPR–Cpf1, … There is more to come in the CRISPR story KQED Future of You Editing the future: A brief introduction to CRISPR |
FierceBiotech |
ImmusanT’s celiac disease immunotherapy passes first clinical test
FierceBiotech ImmusanT’s big idea is to use a trio of three peptides as an immunotherapy that it hopes will encourage the T cells involved in the inflammatory reaction in celiac disease to become tolerant to gluten. After a first course to induce tolerance, the … ImmusanT Announces Completion of Phase 1b Clinical Trial of Nexvax2Business Wire (press release) |